FI930270L - Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner - Google Patents

Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner Download PDF

Info

Publication number
FI930270L
FI930270L FI930270A FI930270A FI930270L FI 930270 L FI930270 L FI 930270L FI 930270 A FI930270 A FI 930270A FI 930270 A FI930270 A FI 930270A FI 930270 L FI930270 L FI 930270L
Authority
FI
Finland
Prior art keywords
framstaellningsfoerfaranden
farmaceutiska
cefalosporiner
homologer
kompositioner
Prior art date
Application number
FI930270A
Other languages
English (en)
Finnish (fi)
Other versions
FI930270A7 (fi
FI930270A0 (fi
Inventor
John Hargreaves Bateson
George Burton
Stephen Christopher Marti Fell
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of FI930270A0 publication Critical patent/FI930270A0/fi
Publication of FI930270A7 publication Critical patent/FI930270A7/fi
Publication of FI930270L publication Critical patent/FI930270L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI930270A 1990-07-24 1991-07-22 Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner FI930270L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds
PCT/GB1991/001228 WO1992001696A1 (en) 1990-07-24 1991-07-22 Cephalosporins and homologues, preparations and pharmaceutical compositions

Publications (3)

Publication Number Publication Date
FI930270A0 FI930270A0 (fi) 1993-01-22
FI930270A7 FI930270A7 (fi) 1993-03-22
FI930270L true FI930270L (fi) 1993-03-22

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930270A FI930270L (fi) 1990-07-24 1991-07-22 Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner

Country Status (26)

Country Link
EP (2) EP0540606A1 (cs)
JP (2) JPH05509089A (cs)
KR (1) KR100189075B1 (cs)
CN (2) CN1061046C (cs)
AP (1) AP832A (cs)
AT (1) ATE185567T1 (cs)
AU (1) AU648329B2 (cs)
CA (2) CA2359744C (cs)
CZ (1) CZ6493A3 (cs)
DE (2) DE122006000065I2 (cs)
DK (1) DK0540609T3 (cs)
ES (1) ES2137162T3 (cs)
FI (1) FI930270L (cs)
GR (1) GR3031711T3 (cs)
HU (1) HUT63628A (cs)
IE (1) IE912569A1 (cs)
IL (1) IL98909A0 (cs)
LU (1) LU91290I2 (cs)
MX (1) MX9100317A (cs)
MY (1) MY106399A (cs)
NL (1) NL300249I2 (cs)
NO (1) NO930226L (cs)
NZ (1) NZ239061A (cs)
PT (1) PT98426A (cs)
WO (2) WO1992001696A1 (cs)
YU (1) YU129691A (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
AU3264393A (en) * 1992-01-22 1993-09-01 Smithkline Beecham Plc 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
AU4398297A (en) * 1996-10-02 1998-04-24 Daiichi Pharmaceutical Co., Ltd. Method for esterifying carboxylic compounds
FR2776292B1 (fr) 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
PT1339723E (pt) * 2000-12-04 2006-06-30 Pfizer Prod Inc Processo e derivados esteres uteis para a preparacao de cefalosporinas
AU2002223943B2 (en) * 2000-12-04 2006-10-05 Pfizer Products Inc. Coupling process and intermediates useful for preparing cephalosphorins
US7378408B2 (en) 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
EP2794627B1 (en) 2011-12-22 2018-09-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
TW201408688A (zh) 2012-05-25 2014-03-01 Janssen R & D Ireland 尿嘧啶基螺氧環丁烷（ｓｐｉｒｏｏｘｅｔａｎｅ）核苷類
PT2935303T (pt) 2012-12-21 2021-04-30 Alios Biopharma Inc 4'-fluoro-nucleósidos, 4'-fluoro-nucleótidos e seus análogos para o tratamento de hcv
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
BR112021003156A2 (pt) 2018-08-23 2021-05-11 Seagen, Inc. composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit.
EP4069691B1 (en) 2019-12-06 2024-09-18 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
AU2021224588B2 (en) 2020-02-18 2024-07-18 Gilead Sciences, Inc. Antiviral compounds
TWI874791B (zh) 2020-02-18 2025-03-01 美商基利科學股份有限公司 抗病毒化合物
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
CN114213433B (zh) * 2020-06-08 2023-03-24 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物的制备方法
EP4323362B1 (en) 2021-04-16 2025-05-07 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
PT4347031T (pt) 2021-06-04 2026-01-19 Vertex Pharma Carboxamidas de n-(hidroxialquil(hetero)aril)tetrahidrofurano como moduladores dos canais de sódio
JP7719954B2 (ja) 2021-08-18 2025-08-06 ギリアード サイエンシーズ， インコーポレイテッド リン脂質化合物並びにその製造方法及び使用方法
CN121181574B (zh) * 2025-11-24 2026-02-24 重庆汉佩生物科技有限公司 一种头孢维星衍生物和应用以及制备方法
CN121181573B (zh) * 2025-11-24 2026-02-27 重庆汉佩生物科技有限公司 一种含c-3位四氢呋喃头孢菌素衍生物和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
NL7305936A (cs) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
FI930270A7 (fi) 1993-03-22
MX9100317A (es) 1992-02-28
WO1992001695A1 (en) 1992-02-06
EP0540609B1 (en) 1999-10-13
EP0540609A1 (en) 1993-05-12
DK0540609T3 (da) 1999-12-27
CA2087967A1 (en) 1992-01-25
PT98426A (pt) 1992-05-29
GR3031711T3 (en) 2000-02-29
CN1223859A (zh) 1999-07-28
AU8222491A (en) 1992-02-18
IL98909A0 (en) 1992-07-15
DE69131714T2 (de) 2000-02-24
HUT63628A (en) 1993-09-28
JPH05509305A (ja) 1993-12-22
AU648329B2 (en) 1994-04-21
WO1992001696A1 (en) 1992-02-06
MY106399A (en) 1995-05-30
HU9300177D0 (en) 1993-04-28
ATE185567T1 (de) 1999-10-15
IE912569A1 (en) 1992-01-29
CA2359744C (en) 2007-02-13
JP2851428B2 (ja) 1999-01-27
KR100189075B1 (ko) 1999-06-01
KR930701456A (ko) 1993-06-11
JPH05509089A (ja) 1993-12-16
NL300249I1 (nl) 2007-02-01
EP0540606A1 (en) 1993-05-12
AP9100305A0 (en) 1991-07-31
AP832A (en) 2000-05-03
CN1061046C (zh) 2001-01-24
ES2137162T3 (es) 1999-12-16
CA2359744A1 (en) 1992-02-06
CN1111410C (zh) 2003-06-18
CZ6493A3 (en) 1994-04-13
FI930270A0 (fi) 1993-01-22
CN1060469A (zh) 1992-04-22
NL300249I2 (en) 2007-02-01
NO930226D0 (no) 1993-01-22
NO930226L (no) 1993-03-23
NZ239061A (en) 1993-11-25
YU129691A (sh) 1994-01-20
DE122006000065I1 (de) 2007-03-01
DE69131714D1 (de) 1999-11-18
CA2087967C (en) 2002-09-10
DE122006000065I2 (de) 2007-09-13
LU91290I2 (fr) 2007-01-22

Similar Documents

Publication Publication Date Title
FI906105A0 (fi) Laett oeppningsbar foerpackningspaose och stoedstaellning samt framstaellningsfoerfarande.
FI930270L (fi) Cefalosporiner och homologer, framstaellningsfoerfaranden samt farmaceutiska kompositioner
FI905843A7 (fi) Foerfarande och anordning foer granskning av rakheten av hissgejder och foer raettande av avrikelser samt maetanordning.
FI920522A0 (fi) Ytaktiva cykliska amidokarboxi- foereningar samt deras syntes och anvaendning.
FI911921A7 (fi) Synkronisationsfoerfarande foer sdh -system samt foerfarande och kopplingsanordning foer igenkaenning av olika datastrukturer.
FI905492A0 (fi) Mejeriprodukt samt foerfarande och anlaeggning foer framstaellning av denna.
FI904370A7 (fi) Foerfarande foer tillverkning av sandwichelement bestaoende av en kaerna av mineralullslameller och ytskikt exempelvis av plaot samt en anordning foer utfoerande av foerfarandet.
FI900494A0 (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande.
FI904421A0 (fi) Pyridinylkinolonfoereningar samt deras framstaellning och anvaendning.
FI904281L (fi) Dynamiskt spaenningsintegreringsfoerfarande samt kopplingar foer utfoerande och tillaempande av foerfarandet.
FI911460L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI905920A7 (fi) Foerfarande foer riktande av bergborranordningensmatarbalk samt bergborranordning och maetningsanordning.
FI903310A7 (fi) Ledningskanal foer kablar och ledningar samt daertill anslutbara apparatdosor.
FI911462L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI923763L (fi) Inklaednad av bergvaeggar saosoem tunnlar och dylikt, samt saett foer att aostadkomma inklaednaden
FI911461L (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
FI913563L (fi) Foerfarande foer flamraffinering av tenn - och blyhaltigt primaerkoppar och kopparavfall i invaendigt basiskt beklaedda ungnar samt en slaggbildningsblandning foer utfoerande av dylik raffinering.
FI921551A0 (fi) Indolderivat samt deras fram- staellning och anvaendning.
FI900479A0 (fi) Foerfarande och anordning foer predikterande kodning.
FI902014A0 (fi) Foerfarande och anordning foer skjutoevning.
FI900276A7 (fi) Stenelement samt foerfarande och anordning foer bearbetning av detsamma.
FI910643A7 (fi) Inspelning samt foerfarande och anordning foer inspelnings- och ljudalstring.
FI900132A0 (fi) Tryckreglering i oljeeldstad och styrning v vaermevaexling.
FI924818A0 (fi) Cdr-ympade anti-icam-1-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning
FI83361B (fi) Fogkonstruktion och foerstycke.